Core Viewpoint - Morgan Stanley increased its stake in Zai Lab (09688) by acquiring 1,920,096 shares at a price of HKD 13.3426 per share, totaling approximately HKD 25.6191 million, raising its ownership to about 56,470,300 shares, which represents 5.04% of the company [1] Group 1 - Morgan Stanley's recent acquisition indicates a positive outlook on Zai Lab's potential growth and market position [1] - The total investment made by Morgan Stanley in this transaction is approximately HKD 25.6191 million [1] - Following the purchase, Morgan Stanley's total shareholding in Zai Lab is now approximately 56,470,300 shares [1] Group 2 - The per-share purchase price of HKD 13.3426 reflects the current valuation of Zai Lab in the market [1] - The increase in ownership percentage to 5.04% may influence market perception and investor confidence in Zai Lab [1] - This transaction highlights the ongoing interest from institutional investors in Zai Lab's stock [1]
摩根大通增持再鼎医药(09688)约192.01万股 每股作价约13.34港元